FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Waldemar Priebe

Research Profile

Chemicals & Drugs

Anatomy

Living Beings

Mouse

Physiology

Genes & Molecular Sequences

Molecular Structure

Co-author Network

Publications

TOP 3
Izabela Fokt; Timothy Madden; Charles Conrad; Mark Emmett; Stanislaw Skora; Waldemar Priebe
D-Glucose and D-mannose-based metabolic probes. Part 3: Synthesis of specifically deuterated D-glucose, D-mannose, and 2-deoxy-D-glucose.
Jeannine Garnett; Anupama E Gururaj; Kristen S Hill; Khatri Latha; Waldemar Priebe; Brian Vaillant; Jun Yao; Vaibhav Chumbalkar; Howard Colman; LA Elferink; Oliver Bogler
Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cells.
Mustafa Aziz Hatiboglu; Michael A Davies; Gregory N Fuller; Ling-Yuan Kong; Kayla Anne McEnery; Waldemar Priebe; Wei Qiao; Yongtao Wang; Jun Wei; Amy B Heimberger
The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Waldemar Priebe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Izabela Fokt; Timothy Madden; Charles Conrad; Mark Emmett; Stanislaw Skora; Waldemar Priebe
D-Glucose and D-mannose-based metabolic probes. Part 3: Synthesis of specifically deuterated D-glucose, D-mannose, and 2-deoxy-D-glucose.
Carbohydrate research 2013;368():111-9.
2013: Jeannine Garnett; Anupama E Gururaj; Kristen S Hill; Khatri Latha; Waldemar Priebe; Brian Vaillant; Jun Yao; Vaibhav Chumbalkar; Howard Colman; LA Elferink; Oliver Bogler
Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cells.
Neoplasia (New York, N.Y.) 2013;15(1):73-84.
2012: Mustafa Aziz Hatiboglu; Michael A Davies; Gregory N Fuller; Ling-Yuan Kong; Kayla Anne McEnery; Waldemar Priebe; Wei Qiao; Yongtao Wang; Jun Wei; Amy B Heimberger
The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models.
International journal of cancer. Journal international du cancer 2012;131(1):8-17.
2012: Karolina Swiatek-Machado; Piotr Swierk; Wiesław Szeja; Slawomir Szymanski; Aleksandra Ellert-Miklaszewska; Izabela Fokt; Grzegorz Grynkiewicz; Bogdan Lesyng; Jakub Mieczkowski; Waldemar Priebe; Stanislaw Skora; Bozena Kaminska
Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent antitumor activity in glioma cells.
Cancer biology & therapy 2012;13(8):657-70.
2012: Ke Sai; Slawomir Szymanski; Shuzhen Wang; Kenneth Aldape; W K Alfred Yung; Veerakumar Balasubramaniyan; Zhongping Chen; Charles Conrad; Atreyi Dasgupta; Izabela Fokt; Su Guan; Frederick F Lang; Timothy Madden; Waldemar Priebe; Latif Shooshtari Nasrin
Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway.
Journal of neuro-oncology 2012;107(3):487-501.
2011: Vaibhav Kapuria; Alexander Levitzki; David Maxwell; Waldemar Priebe; H D Hollis Showalter; Roderick J Sorenson; Moshe Talpaz; William G Bornmann; Nicholas J Donato
A novel small molecule deubiquitinase inhibitor blocks Jak2 signaling through Jak2 ubiquitination.
Cellular signalling 2011;23(12):2076-85.
2011: Ahmed Ashour Ahmed; Robert C Bast; Izabela Fokt; Juliet Goldsmith; Krystiana A Krzysko; Xiao-Feng Le; Bogdan Lesyng; Waldemar Priebe
A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancer.
Cancer chemotherapy and pharmacology 2011;68(4):1033-44.
2011: A Samanta; B Perazzona; S Chakraborty; Xiaoping Sun; H Modi; R Bhatia; Waldemar Priebe; Ralph B Arlinghaus
Janus kinase 2 regulates Bcr-Abl signaling in chronic myeloid leukemia.
Leukemia 2011;25(3):463-72.
2011: Jun Wei; Adam Wu; Ling-Yuan Kong; Yongtao Wang; Gregory Fuller; Isabella Fokt; Giovanni Melillo; Waldemar Priebe; Amy B Heimberger
Hypoxia potentiates glioma-mediated immunosuppression.
PloS one 2011;6(1):e16195.
2010: Ling-Yuan Kong; Adam S Wu; Tiffany Doucette; Jun Wei; Waldemar Priebe; Gregory N Fuller; Wei Qiao; Raymond Sawaya; Ganesh Rao; Amy B Heimberger
Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(23):5722-33.
2010: Adam Wu; Jun Wei; Ling-Yuan Kong; Yongtao Wang; Waldemar Priebe; Wei Qiao; Raymond Sawaya; Amy B Heimberger
Glioma cancer stem cells induce immunosuppressive macrophages/microglia.
Neuro-oncology 2010;12(11):1113-25.
2010: Ling-Yuan Kong; Alexander Gelbard; Jun Wei; Chantal Reina-Ortiz; Yongtao Wang; Eric C Yang; Yared Hailemichael; Izabela Fokt; Arumugam Jayakumar; Wei Qiao; Gregory N Fuller; Willem W Overwijk; Waldemar Priebe; Amy B Heimberger
Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(9):2550-61.
2010: Jun Wei; Jason Barr; Ling-Yuan Kong; Yongtao Wang; Adam Wu; Amit K Sharma; Joy Gumin; Verlene Henry; Howard Colman; Waldemar Priebe; Raymond Sawaya; Frederick F Lang; Amy B Heimberger
Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway.
Molecular cancer therapeutics 2010;9(1):67-78.
2009: Izabela Fokt; Slawomir Szymanski; Stanislaw Skora; Marcin Cybulski; Timothy Madden; Waldemar Priebe
D-glucose- and D-mannose-based antimetabolites. Part 2. Facile synthesis of 2-deoxy-2-halo-D-glucoses and -D-mannoses.
Carbohydrate research 2009;344(12):1464-73.
2009: Ling-Yuan Kong; Jun Wei; Amit K Sharma; Jason Barr; Mohamed K Abou-Ghazal; Izabela Fokt; Jeffrey Weinberg; Ganesh Rao; Elizabeth Grimm; Waldemar Priebe; Amy B Heimberger
A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells.
Cancer immunology, immunotherapy : CII 2009;58(7):1023-32.
2009: Amy B Heimberger; Ling-Yuan Kong; Mohamed Abou-Ghazal; Chantal Reina-Ortiz; David S Yang; Jun Wei; Wei Qiao; Robert J Schmittling; Gary E Archer; John H Sampson; Nobuyoshi Hiraoka; Waldemar Priebe; Gregory N Fuller; Raymond Sawaya
The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor.
Clinical neurosurgery 2009;56():98-106.
2009: Michael E Kupferman; Arumugam Jayakumar; Ge Zhou; Tong Xie; Yasemin Dakak-Yazici; Mei Zhao; Jun Ju; Mahitosh Mandal; Samar Jasser; Timothy Madden; Jeffrey N Myers; Waldemar Priebe
Therapeutic suppression of constitutive and inducible JAK\STAT activation in head and neck squamous cell carcinoma.
Journal of experimental therapeutics & oncology 2009;8(2):117-27.
2008: Amy B Heimberger; Waldemar Priebe
Small molecular inhibitors of p-STAT3: novel agents for treatment of primary and metastatic CNS cancers.
Recent patents on CNS drug discovery 2008;3(3):179-88.
2008: Ling-Yuan Kong; Mohamed K Abou-Ghazal; Jun Wei; Arup Chakraborty; Wei Sun; Wei Qiao; Gregory N Fuller; Izabela Fokt; Elizabeth A Grimm; Robert J Schmittling; Gary E Archer; John H Sampson; Waldemar Priebe; Amy B Heimberger
A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(18):5759-68.
2008: Yohann CORVIS; Beata Korchowiec; Jacek Korchowiec; Mounia Badis; Ewa Mironiuk-Puchalska; Izabela Fokt; Waldemar Priebe; Ewa Rogalska
Complexation of metal ions in Langmuir films formed with two amphiphilic dioxadithia crown ethers.
The journal of physical chemistry. B 2008;112(35):10953-63.
2008: Srdan Verstovsek; Taghi Manshouri; Alfonso Quintás-Cardama; David Harris; Jorge Cortes; Francis Giles; Andrew Lamb; Waldemar Priebe; Zeev Estrov
WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(3):788-96.
2007: Alessandra Ferrajoli; Stefan Faderl; Quin Van; Patricia Koch; David Harris; Zhiming Liu; Inbal Hazan-Halevy; Yongtao Wang; Hagop M Kantarjian; Waldemar Priebe; Zeev Estrov
WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells.
Cancer research 2007;67(23):11291-9.
2007: S Farzana Hussain; Ling-Yuan Kong; Justin Jordan; Charles Conrad; Timothy Madden; Izabela Fokt; Waldemar Priebe; Amy B Heimberger
A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients.
Cancer research 2007;67(20):9630-6.
2007: Mingzhong Zheng; Waldemar Priebe; Eugene T Walch; Katherine G Roth; Mikyung Han; Chi-Hui Tang; Sangkyou Lee; Nancy J Poindexter; Izabela Fokt; Elizabeth A Grimm
WP760, a melanoma selective drug.
Cancer chemotherapy and pharmacology 2007;60(5):625-33.
2007: Gene L Bidwell; Aisha N Davis; Izabela Fokt; Waldemar Priebe; Drazen Raucher
A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance.
Investigational new drugs 2007;25(4):313-26.
2007: Beata M Gruber; Elzbieta L Anuszewska; Irena Bubko; Aneta Goździk; Izabela Fokt; Waldemar Priebe
Effect of structural modification at the 4, 3', and 2' positions of doxorubicin on topoisomerase II poisoning, apoptosis, and cytotoxicity in human melanoma cells.
Archivum immunologiae et therapiae experimentalis 2007;55(3):193-8.
2007: Geoffrey Bartholomeusz; Moshe Talpaz; Vaibhav Kapuria; Ling-Yuan Kong; Shimei Wang; Zeev Estrov; Waldemar Priebe; Ji Wu; Nicholas J Donato
Activation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells.
Blood 2007;109(8):3470-8.
2007: Arifumi Iwamaru; S Szymanski; Eiji Iwado; Hiroshi Aoki; Tomohisa Yokoyama; Izabela Fokt; Kenneth Hess; Charles Conrad; Timothy Madden; Raymond Sawaya; Seiji Kondo; Waldemar Priebe; Yasuko Kondo
A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo.
Oncogene 2007;26(17):2435-44.
2007: Sylvia Mansilla; Marta Rojas; Marc Bataller; Waldemar Priebe; José Portugal
Circumvention of the multidrug-resistance protein (MRP-1) by an antitumor drug through specific inhibition of gene transcription in breast tumor cells.
Biochemical pharmacology 2007;73(7):934-42.
2007: Gene L Bidwell; Izabela Fokt; Waldemar Priebe; Drazen Raucher
Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin.
Biochemical pharmacology 2007;73(5):620-31.
2007: Yoko Tabe; Linhua Jin; Yuko Tsutsumi-Ishii; Yuanyuan Xu; Teresa McQueen; Waldemar Priebe; Gordon B Mills; Akimichi Ohsaka; Isao Nagaoka; Michael Andreeff; Marina Konopleva
Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells.
Cancer research 2007;67(2):684-94.
2006: Theodore J Lampidis; Metin Kurtoglu; Johnathan Maher; Huaping Liu; AWTAR KRISHAN; Valerie Sheft; Slawomir Szymanski; Izabela Fokt; Witold R Rudnicki; Krzysztof Ginalski; Bogdan Lesyng; Waldemar Priebe
Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells".
Cancer chemotherapy and pharmacology 2006;58(6):725-34.
2006: Elzbieta L Anuszewska; Bozena Chłopkiewicz; Beata M Gruber; Jadwiga Marczewska; Waldemar Priebe; Henryk Skurzak
Estimation of DNA damage and cytotoxicity of anthracycline analogs in human melanoma cells on early and late passages.
Acta poloniae pharmaceutica 2006;63(4):321-4.
2006: Sylvia Mansilla; Waldemar Priebe; José Portugal
Transcriptional changes facilitate mitotic catastrophe in tumour cells that contain functional p53.
European journal of pharmacology 2006;540(1-3):34-45.
2006: Beata M Gruber; Elzbieta L Anuszewska; Iza Roman; Aneta Goździk; Waldemar Priebe; Izabela Fokt
Topoisomerase II alpha expression and cytotoxicity of anthracyclines in human neoplastic cells.
Acta poloniae pharmaceutica 2006;63(1):15-8.
2006: Sylvia Mansilla; Waldemar Priebe; José Portugal
Mitotic catastrophe results in cell death by caspase-dependent and caspase-independent mechanisms.
Cell cycle (Georgetown, Tex.) 2006;5(1):53-60.
2005: José Portugal; Derek J Cashman; John O Trent; Neus Ferrer-Miralles; Teresa Przewloka; Izabela Fokt; Waldemar Priebe; Jonathan B Chaires
A new bisintercalating anthracycline with picomolar DNA binding affinity.
Journal of medicinal chemistry 2005;48(26):8209-19.
2005: Beata M Gruber; Elzbieta L Anuszewska; Irena Bubko; Aneta Gozdzik; Waldemar Priebe; Izabela Fokt
Relationship between topoisomerase II-DNA cleavable complexes, apoptosis and cytotoxic activity of anthracyclines in human cervix carcinoma cells.
Anticancer research 2005;25(3B):2193-8.
2005: Stefan Faderl; Alessandra Ferrajoli; David Harris; Quin Van; Waldemar Priebe; Zeev Estrov
WP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute myeloid leukemia (AML).
Anticancer research 2005;25(3B):1841-50.
2005: Bozena Chłopkiewicz; Anna Ejchart; Jadwiga Marczewska; Elzbieta L Anuszewska; Waldemar Priebe
Evaluation of mutagenic and genotoxic activities of new derivatives of anthracyclines.
Acta poloniae pharmaceutica 2005;62(2):99-104.
2005: Johnathan Maher; Niramol Savaraj; Waldemar Priebe; Huaping Liu; Theodore J Lampidis
Differential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with GLUT-1 expression.
Pancreas 2005;30(2):e34-9.
2005: Rajesh R Nair; Heng Wang; Md Saha Jamaluddin; Izabela Fokt; Waldemar Priebe; Douglas D Boyd
A bisanthracycline (WP631) represses uPAR gene expression and cell migration of RKO colon cancer cells by interfering with transcription factor binding to a chromatin-accessible -148/-124 promoter region.
Oncology research 2005;15(5):265-79.
2005: Beata M Gruber; Elzbieta L Anuszewska; Irena Bubko; Teresa Kasprzycka-Guttman; Irena Misiewicz; Katarzyna Skupińska; Waldemar Priebe; Izabela Fokt
Constitutive activation of transcription factor NFkappaB as a possible marker of sensitivity of neoplastic cells to anthracyclines.
Acta poloniae pharmaceutica 2005;62(1):17-23.
2004: Jadwiga Marczewska; Elzbieta L Anuszewska; Waldemar Priebe
The application of the sister chromatid exchange test for evaluation of the novel anthracycline derivatives. Part I.
Acta poloniae pharmaceutica 2004;61 Suppl():22-4.
2004: Alex V Trevino; Barbara Woynarowska; Terence S Herman; Waldemar Priebe; Jan Woynarowski
Enhanced topoisomerase II targeting by annamycin and related 4-demethoxy anthracycline analogues.
Molecular cancer therapeutics 2004;3(11):1403-10.
2004: Keith R Fox; Richard Webster; Robin J Phelps; Izabela Fokt; Waldemar Priebe
Sequence selective binding of bis-daunorubicin WP631 to DNA.
European journal of biochemistry / FEBS 2004;271(17):3556-66.
2004: Sylvia Mansilla; Waldemar Priebe; José Portugal
Sp1-targeted inhibition of gene transcription by WP631 in transfected lymphocytes.
Biochemistry 2004;43(23):7584-92.
2004: Kazuhiro Ashikawa; Shishir Shishodia; Izabela Fokt; Waldemar Priebe; Bharat B Aggarwal
Evidence that activation of nuclear factor-kappaB is essential for the cytotoxic effects of doxorubicin and its analogues.
Biochemical pharmacology 2004;67(2):353-64.
2004: Beata M Gruber; Elzbieta L Anuszewska; Waldemar Priebe
The effect of new anthracycline derivatives on the induction of apoptotic processes in human neoplastic cells.
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2004;42(2):127-30.
2004: Gregory Maschek; Niramol Savaraj; Waldemar Priebe; Paul Braunschweiger; Kara Hamilton; George F Tidmarsh; Linda R De Young; Theodore J Lampidis
2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo.
Cancer research 2004;64(1):31-4.
2003: Fuks Leon; Krystyna Samochocka; Romana Anulewicz-Ostrowska; Marcin Kruszewski; Waldemar Priebe; Wlodzimierz Lewandowski
Structure and biological activity of cationic [PtLCl(DMSO)]NO(3).DMSO complex containing a chelated diaminosugar: methyl-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxopyranoside.
European journal of medicinal chemistry 2003;38(7-8):775-80.
2003: Hayet Tayeb-Bel Haj; Milena Salerno; Waldemar Priebe; Henryk Kozlowski; Arlette Garnier-Suillerot
New findings in the study on the intercalation of bisdaunorubicin and its monomeric analogues with naked and nucleus DNA.
Chemico-biological interactions 2003;145(3):349-58.
2003: Silvia Villamarín; Sylvia Mansilla; Neus Ferrer-Miralles; Waldemar Priebe; José Portugal
A comparative analysis of the time-dependent antiproliferative effects of daunorubicin and WP631.
European journal of biochemistry / FEBS 2003;270(4):764-70.
2003: Marcin Kruszewski; Elzbieta Bouzyk; Tomasz Oldak; Krystyna Samochocka; Fuks Leon; Wlodzimierz Lewandowski; Izabela Fokt; Waldemar Priebe
Differential toxic effect of cis-platinum(II) and palladium(II) chlorides complexed with methyl 3,4-diamine-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside in mouse lymphoma cell lines differing in DSB and NER repair ability.
Teratogenesis, carcinogenesis, and mutagenesis 2003;Suppl 1():1-11.
2002: Huaping Liu; Niramol Savaraj; Waldemar Priebe; Theodore J Lampidis
Hypoxia increases tumor cell sensitivity to glycolytic inhibitors: a strategy for solid tumor therapy (Model C).
Biochemical pharmacology 2002;64(12):1745-51.
2002: Daniel J Booser; Francisco J Esteva; Edgardo Rivera; Vicente Valero; Laura Guerra; Waldemar Priebe; Gabriel N Hortobagyi
Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer.
Cancer chemotherapy and pharmacology 2002;50(1):6-8.
2002: Milena Salerno; Teresa Przewloka; Izabela Fokt; Waldemar Priebe; Arlette Garnier-Suillerot
Preferential efflux by P-glycoprotein, but not MRP1, of compounds containing a free electron donor amine.
Biochemical pharmacology 2002;63(8):1471-9.
2002: Silvia Villamarín; Neus Ferrer-Miralles; Sylvia Mansilla; Waldemar Priebe; José Portugal
Induction of G(2)/M arrest and inhibition of c-myc and p53 transcription by WP631 in Jurkat T lymphocytes.
Biochemical pharmacology 2002;63(7):1251-8.
2001: Stefan Faderl; Zeev Estrov; Hagop M Kantarjian; David Harris; Quin Van; Izabela Fokt; Teresa Przewloka; C Godlewski; Jan Woynarowski; Waldemar Priebe
WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.
Anticancer research 2001;21(6A):3777-84.
2001: Chatchanok Loetchutinat Udomtanakunchai; C Heywang; Waldemar Priebe; Arlette Garnier-Suillerot
The absence of stereoselective P-glycoprotein- and multidrug resistance-associated protein-mediated transport of daunorubicin.
Biochemical pharmacology 2001;62(5):561-7.
2001: Chatchanok Loetchutinat Udomtanakunchai; Waldemar Priebe; Arlette Garnier-Suillerot
Drug sequestration in cytoplasmic organelles does not contribute to the diminished sensitivity of anthracyclines in multidrug resistant K562 cells.
European journal of biochemistry / FEBS 2001;268(16):4459-67.
2001: H Liu; Y P Hu; Niramol Savaraj; Waldemar Priebe; Theodore J Lampidis
Hypersensitization of tumor cells to glycolytic inhibitors.
Biochemistry 2001;40(18):5542-7.
2001: Frédéric Frézard; Elene C Pereira-Maia; P Quidu; Waldemar Priebe; Arlette Garnier-Suillerot
P-glycoprotein preferentially effluxes anthracyclines containing free basic versus charged amine.
European journal of biochemistry / FEBS 2001;268(6):1561-7.
2001: Waldemar Priebe; Izabela Fokt; Teresa Przewloka; Jonathan B Chaires; José Portugal; John O Trent
Exploiting anthracycline scaffold for designing DNA-targeting agents.
Methods in enzymology 2001;340():529-55.
2001: Arlette Garnier-Suillerot; Carole Marbeuf-Gueye; Milena Salerno; Chatchanok Loetchutinat Udomtanakunchai; Izabela Fokt; M Krawczyk; T Kowalczyk; Waldemar Priebe
Analysis of drug transport kinetics in multidrug-resistant cells: implications for drug action.
Current medicinal chemistry 2001;8(1):51-64.
2001: José Portugal; B Martín; Alejandro Vaquero; N Ferrer; Silvia Villamarín; Waldemar Priebe
Analysis of the effects of daunorubicin and WP631 on transcription.
Current medicinal chemistry 2001;8(1):1-8.
2000: Y Hu; Carlos T Moraes; Niramol Savaraj; Waldemar Priebe; Theodore J Lampidis
Rho(0) tumor cells: a model for studying whether mitochondria are targets for rhodamine 123, doxorubicin, and other drugs.
Biochemical pharmacology 2000;60(12):1897-905.
2000: Carole Marbeuf-Gueye; Waldemar Priebe; Arlette Garnier-Suillerot
Multidrug resistance protein functionality: no effect of intracellular or extracellular pH changes.
Biochemical pharmacology 2000;60(10):1485-9.
2000: Xiaogang Qu; John O Trent; Izabela Fokt; Waldemar Priebe; Jonathan B Chaires
Allosteric, chiral-selective drug binding to DNA.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(22):12032-7.
2000: Jan Hendrik Hooijberg; HERBERT PINEDO; C Vrasdonk; Waldemar Priebe; Jan Lankelma; Henk J Broxterman
The effect of glutathione on the ATPase activity of MRP1 in its natural membranes.
FEBS letters 2000;469(1):47-51.
2000: Daniel J Booser; Roman Perez-Soler; P Cossum; Laura Guerra; Qing-Ping Wu; Yiyu Zou; Waldemar Priebe; Gabriel N Hortobagyi
Phase I study of liposomal annamycin.
Cancer chemotherapy and pharmacology 2000;46(5):427-32.
2000: Witold R Rudnicki; M Kurzepa; T Szczepanik; Waldemar Priebe; Bogdan Lesyng
A simple model for predicting the free energy of binding between anthracycline antibiotics and DNA.
Acta biochimica Polonica 2000;47(1):1-9.
1999: B Martín; Alejandro Vaquero; Waldemar Priebe; José Portugal
Bisanthracycline WP631 inhibits basal and Sp1-activated transcription initiation in vitro.
Nucleic acids research 1999;27(17):3402-9.
1999: Carole Marbeuf-Gueye; D Ettori; Waldemar Priebe; Henryk Kozlowski; Arlette Garnier-Suillerot
Correlation between the kinetics of anthracycline uptake and the resistance factor in cancer cells expressing the multidrug resistance protein or the P-glycoprotein.
Biochimica et biophysica acta 1999;1450(3):374-84.
1998: Waldemar Priebe; M Krawczyk; M Tien Kuo; Y Yamane; Niramol Savaraj; Toshihisa Ishikawa
Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump.
Biochemical and biophysical research communications 1998;247(3):859-63.
1998: Fenfei Leng; Waldemar Priebe; Jonathan B Chaires
Ultratight DNA binding of a new bisintercalating anthracycline antibiotic.
Biochemistry 1998;37(7):1743-53.
1998: Carole Marbeuf-Gueye; Henk J Broxterman; F Dubru; Waldemar Priebe; Arlette Garnier-Suillerot
Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
Molecular pharmacology 1998;53(1):141-7.
1997: GG Hu; X Shui; Fenfei Leng; Waldemar Priebe; Jonathan B Chaires; Loren Dean Williams
Structure of a DNA-bisdaunomycin complex.
Biochemistry 1997;36(20):5940-6.
1997: Roman Perez-Soler; N Neamati; Yiyu Zou; E Schneider; L Austin Doyle; Michael Andreeff; Waldemar Priebe; Yi-He Ling
Annamycin circumvents resistance mediated by the multidrug resistance-associated protein (MRP) in breast MCF-7 and small-cell lung UMCC-1 cancer cell lines selected for resistance to etoposide.
International journal of cancer. Journal international du cancer 1997;71(1):35-41.
1997: Theodore J Lampidis; D Kolonias; T Podona; Mervyn Israel; A R Safa; Leonard Lothstein; Niramol Savaraj; H Tapiero; Waldemar Priebe
Circumvention of P-GP MDR as a function of anthracycline lipophilicity and charge.
Biochemistry 1997;36(9):2679-85.
1997: Jonathan B Chaires; Fenfei Leng; Teresa Przewloka; Izabela Fokt; Yi-He Ling; Roman Perez-Soler; Waldemar Priebe
Structure-based design of a new bisintercalating anthracycline antibiotic.
Journal of medicinal chemistry 1997;40(3):261-6.
1996: L Gallois; Marina M L Fiallo; Alain Laigle; Waldemar Priebe; Arlette Garnier-Suillerot
The overall partitioning of anthracyclines into phosphatidyl-containing model membranes depends neither on the drug charge nor the presence of anionic phospholipids.
European journal of biochemistry / FEBS 1996;241(3):879-87.
1996: Yi-Gui Gao; Waldemar Priebe; Andrew H-J Wang
Substitutions at C2' of daunosamine in the anticancer drug daunorubicin alter its DNA-binding sequence specificity.
European journal of biochemistry / FEBS 1996;240(2):331-5.
1996: U Consoli; Waldemar Priebe; Yi-He Ling; R Mahadevia; M Griffin; Shourong Zhao; Roman Perez-Soler; Michael Andreeff
The novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines.
Blood 1996;88(2):633-44.
1996: Yi-He Ling; A K el-Naggar; Waldemar Priebe; Roman Perez-Soler
Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.
Molecular pharmacology 1996;49(5):832-41.
1996: Béatrice Jollès; Alain Laigle; Waldemar Priebe; Arlette Garnier-Suillerot
Comparison of DNA sequence selectivity of anthracycline antibiotics and their 3'-hydroxylated analogs.
Chemico-biological interactions 1996;100(2):165-76.
1996: Jonathan B Chaires; S Satyanarayana; D Suh; I Fokt; T Przewloka; Waldemar Priebe
Parsing the free energy of anthracycline antibiotic binding to DNA.
Biochemistry 1996;35(7):2047-53.
1996: Yiyu Zou; Waldemar Priebe; Roman Perez-Soler
Lyophilized preliposomal formulation of the non-cross-resistant anthracycline annamycin: effect of surfactant on liposome formation, stability and size.
Cancer chemotherapy and pharmacology 1996;39(1-2):103-8.
1995: T Ishikawa; K Akimaru; M Tien Kuo; Waldemar Priebe; M Suzuki
How does the MRP/GS-X pump export doxorubicin?
Journal of the National Cancer Institute 1995;87(21):1639-40.
1995: Yiyu Zou; Yi-He Ling; S Reddy; Waldemar Priebe; Roman Perez-Soler
Effect of vesicle size and lipid composition on the in vivo tumor selectivity and toxicity of the non-cross-resistant anthracycline annamycin incorporated in liposomes.
International journal of cancer. Journal international du cancer 1995;61(5):666-71.
1995: Yi-He Ling; Yiyu Zou; Waldemar Priebe; Roman Perez-Soler
Partial circumvention of multi-drug resistance by annamycin is associated with comparable inhibition of DNA synthesis in the nuclear matrix of sensitive and resistant cells.
International journal of cancer. Journal international du cancer 1995;61(3):402-8.
1994: M N Borrel; Marina M L Fiallo; Waldemar Priebe; Arlette Garnier-Suillerot
P-glycoprotein-mediated efflux of hydroxyrubicin, a neutral anthracycline derivative, in resistant K562 cells.
FEBS letters 1994;356(2-3):287-99.
1994: J Y Zhao; Niramol Savaraj; R Song; Waldemar Priebe; M Tien Kuo
Overexpression of P-glycoprotein but not its mRNA in multidrug resistant cells selected with hydroxyrubicin.
Anticancer research 1994;14(5A):1735-42.
1994: Eric Solary; Yi-He Ling; Roman Perez-Soler; Waldemar Priebe; Yves Pommier
Hydroxyrubicin, a deaminated derivative of doxorubicin, inhibits mammalian DNA topoisomerase II and partially circumvents multidrug resistance.
International journal of cancer. Journal international du cancer 1994;58(1):85-94.
1994: Yiyu Zou; Yi-He Ling; NT Van; Waldemar Priebe; Roman Perez-Soler
Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties.
Cancer research 1994;54(6):1479-84.
1994: Roman Perez-Soler; Yi-He Ling; Yiyu Zou; Waldemar Priebe
Cellular pharmacology of the partially non-cross-resistant anthracycline annamycin entrapped in liposomes in KB and KB-V1 cells.
Cancer chemotherapy and pharmacology 1994;34(2):109-18.
1993: Yi-He Ling; Waldemar Priebe; Roman Perez-Soler
Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells.
Cancer research 1993;53(8):1845-52.
1993: Yi-He Ling; Waldemar Priebe; Li-Ying Yang; T G Burke; Y Pommier; Roman Perez-Soler
In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranes.
Cancer research 1993;53(7):1583-9.
1993: Waldemar Priebe; NT Van; T G Burke; Roman Perez-Soler
Removal of the basic center from doxorubicin partially overcomes multidrug resistance and decreases cardiotoxicity.
Anti-cancer drugs 1993;4(1):37-48.
1993: Yiyu Zou; Waldemar Priebe; Yi-He Ling; Roman Perez-Soler
Organ distribution and tumor uptake of annamycin, a new anthracycline derivative with high affinity for lipid membranes, entrapped in multilamellar vesicles.
Cancer chemotherapy and pharmacology 1993;32(3):190-6.
1992: Waldemar Priebe; N Neamati; Roman Perez-Soler
3'-Hydroxyesorubicin halogenated at C-2'.
The Journal of antibiotics 1992;45(3):386-93.
1992: Roman Perez-Soler; Waldemar Priebe
Liposomal formulation and antitumor activity of 14-O-palmitoyl-hydroxyrubicin.
Cancer chemotherapy and pharmacology 1992;30(4):267-71.
1990: Roman Perez-Soler; Waldemar Priebe
Anthracycline antibiotics with high liposome entrapment: structural features and biological activity.
Cancer research 1990;50(14):4260-6.
1990: Waldemar Priebe; N Neamati; Roman Perez-Soler
3'-Hydroxyesorubicin. Synthesis and antitumor activity.
The Journal of antibiotics 1990;43(7):838-46.